<- Go Home
Cizzle Biotechnology Holdings Plc
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom. It develops a non-invasive blood immunoassay test for early lung cancer detection using CIZ1B biomarker technology. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Market Cap
GBP 10.2M
Volume
1.1M
Cash and Equivalents
GBP 116.0K
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
GBP 0.04
52 Week Low
GBP 0.01
Dividend
N/A
Price / Book Value
-28.00
Price / Earnings
-13.77
Price / Tangible Book Value
-28.00
Enterprise Value
GBP 10.1M
Enterprise Value / EBITDA
N/A
Operating Income
-GBP 731.0K
Return on Equity
535.66%
Return on Assets
-123.98
Cash and Short Term Investments
GBP 116.0K
Debt
N/A
Equity
-GBP 340.0K
Revenue
N/A
Unlevered FCF
-GBP 283.9K
Sector
Biotechnology
Category
N/A